The article reports that Health Canada has approved the manufacturing and distribution of Sanofi-Aventis SA's Eloxatin. The drug approval is based on several clinical data collected over several years, which demonstrates the effectiveness of the drug in combination with infusional 5-fluorouracil and ...
Health Canada grants approval of Acadia’s Rett syndrome treatment TheFlyOct 17, 2024, 04:10 AM A+ A- Acadia Pharmaceuticals announced that Health Canada has granted marketing authorization of DAYBUE for the treatment of Rett syndrome in adult and pediatric patients two years of age and older ...
This indication follows the July 2022 Health Canada approval of RINVOQ for adults with active ankylosing spondylitis (AS) who have had an inadequate response to a biologic DMARD or when use of those therapies is inadvisable, making RINVOQ the first and only JAK ...
SPharm is one of Canada's top Regulatory experts or Drug & Health products, Clinical Trial Applications & Health Canada approval process.
ATLAS (NCT02951052)is a Phase 3, open-label, active-controlled, multicenter, parallel-group, non-inferiority study designed to assess the antiviral activity, safety and tolerability of a two-drug regimen of long-acting, injectable rilpivirine and cabotegra...
management—early morning functioning.JORNAY PM™ offers an effective treatment that assists in better morning routines. This new treatment is a welcome addition to the growing options available for ADHD management in Canada”, said Dr. ...
List of Approved drugs containing Salurex listed with Health Canada in the Drug Product Database (DPD)
s regulatory application for marketing approval of its single-shot chikungunya vaccine candidate VLA1553 in persons aged 18 years and above, and has determined that the New Drug Submission (NDS) application is sufficiently complete to permit a substantive review. Based on Health Canada’...
Nora Pharma has received approval from Health Canada for the commercialization of NIOPEG® (a pegylated form of filgrastim) in Canada. The current market size of pegfilgrastim in Canada is approximately $88 million USD. NIOPEG® is a Biosimilar comparable to t...
The version approved in the U.S. targets newer and more prevalent strains of the Omicron variant than the one submitted for approval in Canada. Canada has already purchased 12 million doses of Moderna’s version of the Omicron vaccine,which includes converting some existing orders for the origin...